BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 25882839)

  • 1. A Point Mutation in the Ubiquitin Ligase RNF170 That Causes Autosomal Dominant Sensory Ataxia Destabilizes the Protein and Impairs Inositol 1,4,5-Trisphosphate Receptor-mediated Ca2+ Signaling.
    Wright FA; Lu JP; Sliter DA; Dupré N; Rouleau GA; Wojcikiewicz RJ
    J Biol Chem; 2015 May; 290(22):13948-57. PubMed ID: 25882839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNF170 protein, an endoplasmic reticulum membrane ubiquitin ligase, mediates inositol 1,4,5-trisphosphate receptor ubiquitination and degradation.
    Lu JP; Wang Y; Sliter DA; Pearce MM; Wojcikiewicz RJ
    J Biol Chem; 2011 Jul; 286(27):24426-33. PubMed ID: 21610068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent gait abnormalities in mice lacking the Rnf170 gene linked to human autosomal-dominant sensory ataxia.
    Kim Y; Kim SH; Kim KH; Chae S; Kim C; Kim J; Shin HS; Lee MS; Kim D
    Hum Mol Genet; 2015 Dec; 24(25):7196-206. PubMed ID: 26433933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Ca2+ in triggering inositol 1,4,5-trisphosphate receptor ubiquitination.
    Alzayady KJ; Wojcikiewicz RJ
    Biochem J; 2005 Dec; 392(Pt 3):601-6. PubMed ID: 16134970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bi-allelic variants in RNF170 are associated with hereditary spastic paraplegia.
    Wagner M; Osborn DPS; Gehweiler I; Nagel M; Ulmer U; Bakhtiari S; Amouri R; Boostani R; Hentati F; Hockley MM; Hölbling B; Schwarzmayr T; Karimiani EG; Kernstock C; Maroofian R; Müller-Felber W; Ozkan E; Padilla-Lopez S; Reich S; Reichbauer J; Darvish H; Shahmohammadibeni N; Tafakhori A; Vill K; Zuchner S; Kruer MC; Winkelmann J; Jamshidi Y; Schüle R
    Nat Commun; 2019 Oct; 10(1):4790. PubMed ID: 31636353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging link between IP
    Gao X; Wojcikiewicz RJH
    Cell Calcium; 2020 Mar; 86():102142. PubMed ID: 31874412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Regulation of Multiple Steps in Inositol 1,4,5-Trisphosphate Signaling by Protein Kinase C Shapes Hormone-stimulated Ca2+ Oscillations.
    Bartlett PJ; Metzger W; Gaspers LD; Thomas AP
    J Biol Chem; 2015 Jul; 290(30):18519-33. PubMed ID: 26078455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometric analysis of type 1 inositol 1,4,5-trisphosphate receptor ubiquitination.
    Sliter DA; Kubota K; Kirkpatrick DS; Alzayady KJ; Gygi SP; Wojcikiewicz RJ
    J Biol Chem; 2008 Dec; 283(51):35319-28. PubMed ID: 18955483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated inositol 1,4,5-trisphosphate receptors are modified by homogeneous Lys-48- and Lys-63-linked ubiquitin chains, but only Lys-48-linked chains are required for degradation.
    Sliter DA; Aguiar M; Gygi SP; Wojcikiewicz RJ
    J Biol Chem; 2011 Jan; 286(2):1074-82. PubMed ID: 21071436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chapter 4 - Inositol 1,4,5-Trisphosphate Receptor Ubiquitination.
    Wright FA; Wojcikiewicz RJ
    Prog Mol Biol Transl Sci; 2016; 141():141-59. PubMed ID: 27378757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN counteracts FBXL2 to promote IP3R3- and Ca
    Kuchay S; Giorgi C; Simoneschi D; Pagan J; Missiroli S; Saraf A; Florens L; Washburn MP; Collazo-Lorduy A; Castillo-Martin M; Cordon-Cardo C; Sebti SM; Pinton P; Pagano M
    Nature; 2017 Jun; 546(7659):554-558. PubMed ID: 28614300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane Protein Quantity Control at the Endoplasmic Reticulum.
    Printsev I; Curiel D; Carraway KL
    J Membr Biol; 2017 Aug; 250(4):379-392. PubMed ID: 27743014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of the erlin1/2 complex to the third intralumenal loop of IP
    Gao X; Bonzerato CG; Wojcikiewicz RJH
    J Biol Chem; 2022 Jun; 298(6):102026. PubMed ID: 35568199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutation in the RNF170 gene causes autosomal dominant sensory ataxia.
    Valdmanis PN; Dupré N; Lachance M; Stochmanski SJ; Belzil VV; Dion PA; Thiffault I; Brais B; Weston L; Saint-Amant L; Samuels ME; Rouleau GA
    Brain; 2011 Feb; 134(Pt 2):602-7. PubMed ID: 21115467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IP3 receptor signaling in cell functions and diseases.
    Mikoshiba K
    Adv Biol Regul; 2015 Jan; 57():217-27. PubMed ID: 25497594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant IP
    Ando H; Hirose M; Mikoshiba K
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):12259-12264. PubMed ID: 30429331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E3 ubiquitin ligase RNF170 inhibits innate immune responses by targeting and degrading TLR3 in murine cells.
    Song X; Liu S; Wang W; Ma Z; Cao X; Jiang M
    Cell Mol Immunol; 2020 Aug; 17(8):865-874. PubMed ID: 31076723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretagogues cause ubiquitination and down-regulation of inositol 1, 4,5-trisphosphate receptors in rat pancreatic acinar cells.
    Wojcikiewicz RJ; Ernst SA; Yule DI
    Gastroenterology; 1999 May; 116(5):1194-201. PubMed ID: 10220512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin Ligase RNF138 Promotes Episodic Ataxia Type 2-Associated Aberrant Degradation of Human Ca
    Fu SJ; Jeng CJ; Ma CH; Peng YJ; Lee CM; Fang YC; Lee YC; Tang SC; Hu MC; Tang CY
    J Neurosci; 2017 Mar; 37(9):2485-2503. PubMed ID: 28167673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inositol 1,4,5-trisphosphate-mediated sarcoplasmic reticulum-mitochondrial crosstalk influences adenosine triphosphate production via mitochondrial Ca2+ uptake through the mitochondrial ryanodine receptor in cardiac myocytes.
    Seidlmayer LK; Kuhn J; Berbner A; Arias-Loza PA; Williams T; Kaspar M; Czolbe M; Kwong JQ; Molkentin JD; Heinze KG; Dedkova EN; Ritter O
    Cardiovasc Res; 2016 Oct; 112(1):491-501. PubMed ID: 27496868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.